11.7.2 Pathophysiology

As the mitral surface area decreases, the PLA progressively increases, dilating the atrium; this dilation slows the rise in pressure by increasing atrial compliance. The Gorlin formula used in catheterisation shows that flow and pressure gradient across an orifice are geometrically related [4,6]:
 
MSA (cm2) = K · CO / √ΔPm
where:    CO = cardiac output (L/min)
ΔPm = mean pressure gradient (mmHg)
K = constant
 
From this it can be deduced that the transvalvular pressure gradient is a function of the square of the flow velocity (ΔP ≈ V2 ), regardless of the surface area of the valve. This is also demonstrated by Bernoulli's equation: ΔP = 4 (Vmax )2 . A doubling of cardiac output therefore quadruples the pressure gradient and increases P by the same amount. A mitral stenosis that is asymptomatic at rest will therefore quickly become limiting during exercise. Exercise, stress, hypervolemia, pregnancy or hyperthyroidism are all responsible for a sudden increase in PLA, causing pulmonary interstitial fluid leak, leading to acute dyspnoea and the risk of pulmonary oedema. 
 
The resistance across a valve stenosis depends on the degree of valve opening and the blood flow through the valve. It is given by equation [1]:
 
RES = K · CO / AS2
 
where: RES = total resistance
CO = cardiac output (L/min)
AS = area surface (cm)2
K = constant (1'333)
 
Resistance, and therefore pressure gradient and upstream pressure (in this case PLA), increases linearly with flow but exponentially with decreasing orifice area. This explains the decompensation induced by pregnancy in a previously well-tolerated mitral stenosis and the large benefit obtained by widening with commissurotomy, even if the orifice area remains modest.
 
As the tachycardia shortens diastole more than systole, the acceleration of the heart rate reduces the time available for the volume of each cardiac cycle to pass through the mitral valve, which has a very restricted flow; the flow must accelerate, so the gradient increases geometrically. The result is hypertension in the left atrium, which affects the pulmonary veins and causes pulmonary congestion. In addition, the low filling capacity and small size of the LV limit stroke volume, which can hardly increase when the heart rate slows down. Cardiac output is therefore doubly limited in relation to the heart rate.
  • Tachycardia reduces diastolic filling, which is very slow;
  • Bradycardia reduces flow because the systolic volume is fixed and low. 
 LV filling is less dependent on atrial contraction than when ventricular compliance is impaired [8]. It is the acceleration of the total ventricular rate that causes haemodynamic decompensation during the transition to AF. Although sinus rhythm has an electrical advantage, it is not necessarily effective. This is because the huge atrium of mitral stenosis, with its thin dilated wall, is unable to generate a pressure to overcome the valve obstruction. This electro-mechanical dissociation can be seen on Doppler echo: despite sinus rhythm, there is no atrial contraction A flow through the mitral valve in telediastole. In the LA cavity, which can be up to 350 mL, the flow is extremely slow. On echocardiography, we usually see a slow swirling of the blood mass, resembling wisps of smoke (spontaneous contrast). The risk of mural thrombus is high, particularly in the atrial appendage (LAA) where congestion is marked (Figure 11.89); anticoagulation is recommended (anti-vitamin K agent for INR 2-3) as the risk of arterial embolism is high.
 
Fig11 89 en
 
 Figure 11.89: Left atrial congestion in mitral stenosis. A: Spontaneous contrast in the left atrial appendage (prethrombotic state). B: Presence of a thrombus in the left atrial appendage. C: Pulsed Doppler flow in the left atrial appendage; on the left, normal flow consists of a rapid round trip during atrial contraction and relaxation (Vmax 0.5 m/s); in atrial fibrillation (on the right), the flow is anarchic and of low velocity (Vmax 0.1-0.2 m/s). D: Example of flow in atrial fibrillation recorded in the body of the left atrial appendage (same case as in Figure B).
 
 The LV is generally small in pure mitral stenosis, but systolic function is preserved; EF is normal in 75% of patients [2]. Ventricular mass is normal or reduced. Alterations in segmental kinetics often occur at the base of the LV because the stiffness of the mitral valve prevents normal contraction of the underlying segments [10]. Function may be reduced by concomitant myocarditis specific to ARF, which occurs in 20% of cases.

Pulmonary hypertension (PHT) is common in mitral stenosis because mean PLA remains elevated throughout the cardiac cycle, whereas in MI it is elevated only during systole. This chronic increase in PLA affects the pulmonary veins and induces pulmonary venous hypertension by stasis (postcapillary hypertension). The accumulation of interstitial fluid impairs gas exchange, leading to dyspnoea. Work of breathing is increased. This is followed by a reactive increase in PAR, which becomes fixed in the long term (precapillary hypertension). This is mainly responsible for the increase in LV afterload, as it is out of proportion to the left atrial pressure [3]. It is an adaptive phenomenon that restricts flow to the left heart, reduces blood accumulation in the LA and limits the risk of pulmonary oedema [9,11]. This leads to a cascade of right heart dysfunction: RV hypertrophy and dilatation, tricuspid regurgitation, RA dilatation and systemic venous stasis (see Figure 11.86). When resting systolic PAP exceeds 50 mmHg (mean PAP ≥ 35 mmHg), the functional limits of the LV no longer allow exercise, as PAP increases disproportionately. This combination of pre- and post-capillary PHT  triples mortality [7]. The prevalence of PHT is 75% in mitral stenosis but approximately 30% in mitral regurgitation [5]. In general, mitral stenosis is characterised by LV dysfunction but preserved LV function.

Although the left ventricle retains its contractile function, it is unable to vary its output because its filling capacity is limited. It operates at a low and fixed diastolic volume and is unable to increase its rate: when it accelerates, diastolic filling becomes inadequate. It has no preload reserve to modify its position on the Starling curve and improve its systolic performance during exercise: the systolic volume also remains low and fixed. Nor can the LV compensate for arterial vasodilatation or hypovolemia by tachycardia. The P/V loop (Figure 11.90) illustrates the typical haemodynamic situation: normal intraventricular pressures, limited stroke volume (< 50 mL), normal ejection fraction (EF 0.5 - 0.6); ejection work is reduced but pressure work is normal. Stroke volume is limited by the flow through the stenosis and the duration of diastole. Systemic arterial pressure, which is the product of cardiac output and systemic arterial resistance (SAP ≈ CO · SAR), is essentially dependent on SAR, which must remain high.

Fig11 90 en

 Figure 11.90: Pressure-volume loop in mitral stenosis. The restriction to ventricular filling results in a very small ventricular volume at values of Emax and compliance that are still normal. However, this is not always the case: in rheumatic myocarditis, for example, the LV is dysfunctional, the slope of Emax is reduced and the compliance curve is straightened. Stroke volume (SV) and ejection work are reduced, but pressure work is normal.

 

 Hemodynamic features of mitral stenosis 
LV filling failure: low, fixed stroke volume
Slow diastolic LV filling: intolerance to tachycardia
Intolerance to hypovolemia
Massive increase in PLA on exercise (tachycardia) or hypervolaemia
Dilatation of LA: risk of AF and thrombus
Preserved LV systolic function
Stasis and pulmonary hypertension: venous (postcapillary) and arterial (precapillary) PHT
Pressure overload of RV: dilatation, HRV, dysfunction, tricuspid insufficiency

 

© CHASSOT PG, BETTEX D, August 2011, last update November 2019

 

References

 

  1. BLAIS C, PIBAROT P, DUMESNIL JG, et al. Comparison of valve resistance with effective orifice area regarding flow dependence. Am J Cardiol 2001; 88:45-52
  2. CHOI BW, BACHARACH SL, BARBOUR DI, et al. Left ventricular systolic dysfunction, diastolic filling characteristics and exercise cardiac reserve in mitral stenosis. Am J Cardiol 1995; 75:526-33.
  3. GERGES C, GERGES M, LANG MB, et al. Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension. Chest 2013; 143:758-66
  4. GORLIN R, GORLIN SG. Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and the central circulatory shunts. I. Am Heart J 1951; 41:1-29
  5. HADDAD F, KUDELKO K, MERCIER O, et al. Pulmonary hypertension associated with left heart disease: Characteristics, emerging concepts, and treatment strategies. Progr Cardiovasc Dis 2011; 54:154-67
  6. HAKKI A, ABKULMASSIH IS. A simplified formula for the calculation of stenotic cardiac valves. Circulation 1981; 63:1050-5
  7. LIM GB. Prognostic relevance of pulmonary hypertension in valvular disease. Nat Rev Cardiol 2015; 12:194
  8. MEISNER JS, KEREN G, PAJARO OE, et al. Atrial contribution to ventricular filling in mitral stenosis. Circulation 1991; 84:1469-75
  9. NISHIMURA RA, OTTO CM, BONOW RO, et al. 2014 AHA/ACC Guideline for the management of patients with valvular        heart disease. Circulation 2014; 129:e521-e643
  10. OTTO CM. Mitral stenosis. In: Otto CM, ed. Valvular heart disease 2nd edition. Philadelphia, WB Saunders, 2004; 252-5
  11. VACHIÉRY JL, ADIR Y, BARBERÀ JA, et al. Pulmonary hypertension due to left heart disease. J Am Coll Cardiol 2013; 62:D100-8